Prime Medicine, Inc. (NASDAQ: PRME) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT PRIME MEDICINE, INC.

Prime Medicine, Inc. (NASDAQ: PRME)
Listen to this Section


$3.47
+0.3250 ( +10.35% ) 2.8M

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Clinical Trial Pipeline Stages


Drug Name Stage
PM359DetailsChronic granulomatous disease Phase 1/2

Market Data


Open $3.47
Previous Close $3.14
Volume 2.8M
Market Cap $567.14M
Day Range $3.14 - $3.61
52 Week Range $1.29 - $6.94
Shares Outstanding 180.62M
Change % +10.35%
Net Change ▲ 0.3250
Insider Ownership -0.04%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology
IPO Year2022
CountryUnited States
UnderwriterJ.P. Morgan, Goldman Sachs, Morgan Stanley, Jefferies, more

Insider Ownership Transactions

Total Amount Purchased: 18,118,951.00

Date Type Amount Purchased Purchaser
2025-08-05 Buy 1500000.00 GV 2021 GP, L.L.C.
2025-08-01 Buy 3030300.00 NELSEN ROBERT
2025-08-01 Buy 3030300.00 ARCH Venture Partners X, LLC
2025-08-01 Buy 3030300.00 ARCH Venture Partners XII, LLC
2025-07-01 Buy 21000.00 Liu David R.
2025-06-23 Buy 21000.00 Liu David R.
2025-06-16 Buy 21000.00 Liu David R.
2025-06-12 Buy 21000.00 Liu David R.
2025-05-22 Buy 125000.00 Reine Allan
2025-05-22 Buy 20000.00 Brudnick Richard

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Aug 05, 2025
4 Insider transactions 1 Aug 05, 2025
4 Insider transactions 1 Aug 05, 2025
4 Insider transactions 3 Aug 05, 2025
4 Insider transactions 1 Aug 05, 2025
4 Insider transactions 1 Aug 05, 2025
4 Insider transactions 1 Aug 05, 2025
4 Insider transactions 1 Aug 01, 2025
4 Insider transactions 1 Aug 01, 2025
4 Insider transactions 1 Aug 01, 2025

Latest News


× Before browsing our site, please accept our cookies policy